MK0686 in Postsurgery Dental Pain (0686-002)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 2

Conditions: Pain, Postoperative

Treatments: Drug: MK0686

Study type: Interventional

Funder types: Industry

Identifiers

NCT00533403

2007_617

0686-002

Details and patient eligibility

About

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Enrollment: 114 patients

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
• Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion criteria

• Patient has history of heart disease, asthma, pulmonary disease
• Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind